Perinatal characteristics in relation to incidence of and mortality from prostate cancer

被引:79
|
作者
Ekbom, A
Hsieh, CC
Lipworth, L
Wolk, A
Ponten, J
Adami, HO
Trichopoulos, D
机构
[1] UNIV UPPSALA, DEPT PATHOL, S-75185 UPPSALA, SWEDEN
[2] UNIV MASSACHUSETTS, MED CTR, CTR CANC, WORCESTER, MA 01605 USA
[3] HARVARD UNIV, SCH PUBL HLTH, DEPT EPIDEMIOL, BOSTON, MA 02115 USA
[4] HARVARD UNIV, SCH PUBL HLTH, CTR CANC PREVENT, BOSTON, MA 02115 USA
来源
BMJ-BRITISH MEDICAL JOURNAL | 1996年 / 313卷 / 7053期
关键词
D O I
10.1136/bmj.313.7053.337
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To test the hypothesis that factors causing morbidity and mortality from prostate cancer may operate in utero. Design-Matched case-control study of singleton men born between 1874 and 1946 at one hospital. Setting-Uppsala University Hospital. Subjects-250 patients with prostate cancer and 691 controls, including 80 patients who died from prostate cancer and their 196 matched controls. Main outcome measures-Mother's age at menarche, parity, pre-eclampsia or eclampsia before delivery, age at delivery and socioeconomic status; case or control's birth length and weight, placental weight, prematurity derived from gestational age, and presence of jaundice. Results-Both pre-eclampsia (odds ratio 0, 95% confidence interval 0 to 0.71) and prematurity (0.31, 0.09 to 1.04) were inversely associated with incidence of prostate cancer. Among subjects born full term, placental weight, birth weight, and ponderal index (weight/height(3)) showed non-significant positive associations with prostate cancer incidence, and stronger associations with mortality. Conclusion-Prenatal exposures that are likely correlates of pregnancy hormones and other growth factors are important in prostate carcinogenesis and influence the natural course as well as the occurrence of this cancer.
引用
收藏
页码:337 / 341
页数:5
相关论文
共 50 条
  • [41] Analysis of recent trends in prostate cancer incidence and mortality
    Dennis, LK
    Resnick, MI
    PROSTATE, 2000, 42 (04): : 247 - 252
  • [42] CONTEMPORARY INCIDENCE AND MORTALITY RATES OF NEUROENDOCRINE PROSTATE CANCER
    Moore, Aaron
    Alanee, Shaheen
    Nutt, Max
    Dynda, Danuta
    El-Zawahry, Ahmed
    McVary, Kevin
    JOURNAL OF UROLOGY, 2015, 193 (04): : E34 - E34
  • [43] International trends and patterns of prostate cancer incidence and mortality
    Hsing, AW
    Tsao, L
    Devesa, SS
    INTERNATIONAL JOURNAL OF CANCER, 2000, 85 (01) : 60 - 67
  • [44] Contemporary Incidence and Mortality Rates of Neuroendocrine Prostate Cancer
    Alanee, Shaheen
    Moore, Aaron
    Nutt, Max
    Holland, Bradley
    Dynda, Danuta
    El-Zawahry, Ahmed
    McVary, Kevin T.
    ANTICANCER RESEARCH, 2015, 35 (07) : 4145 - 4150
  • [45] RE: Prostate Cancer Mortality in Areas With High and Low Prostate Cancer Incidence Response
    Stattin, Par
    Carlsson, Sigrid
    Jonsson, Hakan
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (10):
  • [46] Trends and characteristics in prostate cancer mortality in Japan
    Nakata, S
    Takahashi, H
    Ohtake, N
    Takei, T
    Yamanaka, H
    INTERNATIONAL JOURNAL OF UROLOGY, 2000, 7 (07) : 254 - 257
  • [47] Perinatal factors and mortality from breast cancer
    Sanderson, Maureen
    Daling, Janet R.
    Doody, David R.
    Malone, Kathleen E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (10) : 1984 - 1987
  • [48] Incidence and Causes of Perinatal Mortality in Georgia
    Manjavidze, Tinatin
    Rylander, Charlotta
    Skjeldestad, Finn Egil
    Kazakhashvili, Nata
    Anda, Erik Eik
    JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2019, 9 (03) : 163 - 168
  • [49] Incidence and Causes of Perinatal Mortality in Georgia
    Tinatin Manjavidze
    Charlotta Rylander
    Finn Egil Skjeldestad
    Nata Kazakhashvili
    Erik Eik Anda
    Journal of Epidemiology and Global Health, 2019, 9 : 163 - 168
  • [50] Incidence and mortality trends for prostate cancer in 5 French areas from 1982 to 1996
    Chirpaz, E
    Colonna, M
    Menegoz, F
    Grosclaude, P
    Schaffer, P
    Arveux, P
    Lesec'h, JM
    Exbrayat, C
    Schaerer, R
    INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (03) : 372 - 376